Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Free Cash Flow: 2010-2024

Historic Free Cash Flow for CorMedix (CRMD) over the last 14 years, with Dec 2024 value amounting to -$50.7 million.

  • CorMedix's Free Cash Flow rose 322.19% to $30.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $74.4 million, marking a year-over-year increase of 234.06%. This contributed to the annual value of -$50.7 million for FY2024, which is 30.96% down from last year.
  • CorMedix's Free Cash Flow amounted to -$50.7 million in FY2024, which was down 30.96% from -$38.7 million recorded in FY2023.
  • CorMedix's Free Cash Flow's 5-year high stood at -$22.1 million during FY2020, with a 5-year trough of -$50.7 million in FY2024.
  • In the last 3 years, CorMedix's Free Cash Flow had a median value of -$38.7 million in 2023 and averaged -$38.0 million.
  • Data for CorMedix's Free Cash Flow shows a maximum YoY slumped of 57.62% (in 2023) over the last 5 years.
  • CorMedix's Free Cash Flow (Yearly) stood at -$22.1 million in 2020, then declined by 2.27% to -$22.6 million in 2021, then decreased by 8.84% to -$24.6 million in 2022, then tumbled by 57.62% to -$38.7 million in 2023, then crashed by 30.96% to -$50.7 million in 2024.